Today news
About the same in other media
Lupin ties up with Amman Pharma for commercialisation of biosimilar product
Reading now: 590
economictimes.indiatimes.comLupin on Friday said it has tied up with Amman Pharma to market a biosimilar product in the Middle East region. The company has inked a licensing pact for the commercialisation and marketing of Ranibizumab, a biosimilar of Lucentis, in various countries including Saudi Arabia, UAE, Iraq and Lebanon.
Ranibizumab is indicated for the treatment of patients with neovascular age-related macular degeneration, macular edema following retinal vein occlusion (RVO) and diabetic macular edema, among others.
Shares of the company on Friday ended 2.04 per cent down at Rs 1,180.20 apiece on the BSE.
About this in other media
FIFA renews with Qatar Airways as a sponsor for the men's World Cup in 2026 and 2030 abcnews.go.com /5 months ago
Finland erects barriers at border with Russia to control influx of migrants, closes crossing points abcnews.go.com /5 months ago
US Justice Dept. is reportedly ready to settle with Binance for $4 billion cointelegraph.com /5 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
Vote for BJP, we would arrange free darshan of Ram temple in Ayodhya for all: Amit Shah in Telangana
